Welcome to ALB China Capital Markets Forum 2021!

欢迎来到2021年ALB中国资本市场论坛！

	DATE  Thursday, 25 March 2021
	TIME  9.00am to 5.00pm
	VENUE  B1 - Studio 4, JW Marriott Hotel Beijing 北京JW万豪酒店，B1工作室4

REGISTER NOW 

---

 

Jianhai Luan, Partner, Commerce & Finance Law Offices
栾建海，合伙人，通商律师事务所

Mr. Luan Jianhai joined Beijing Commerce & Finance Law Offices in 2006 and possesses over 18 years of professional experience in legal services, he has provided high-quality legal services for numerous domestic and foreign enterprises in the whole process of capital operation, and played an important role in the following projects, including but not limited to:
●The listing of Bloomage Biotech (SH.688363) on STAR Market;
●The removal of VIE structure and the listing of Beijing Infosec Technologies Co., LTD. on STAR Market；
●The subscription for A-shares of Super Shine Co., Ltd by Government of Singapore Investment Corp via private placement;
●The equity swap of Gansu Tristar Petrochemical (Group) Co., Ltd.’s shares by China Electronics Corporation and PetroChina Co., Ltd. (A-share reverse merger project);
●The investment in Beijing-Shanghai High Speed Railway Co., Ltd. by Bank of China Group Investment Ltd.;
●The acquisition of Bohai Steel through bankruptcy reorganization procedure on behalf of Delong Group.

栾建海律师于2006年加入北京市通商律师事务所，拥有逾18年的专业经验，为众多境内外企业的资本运作提供了高质量的全流程法律服务，在包括但不限于以下项目中发挥了重要作用：
●华熙生物科创板上市；
●北京信安世纪拆除VIE架构及科创板上市；
●新加坡政府产业投资有限公司认购广西阳光股份有限公司定向增发A股；
●中国电子信息产业集团公司与中国石油天然气股份有限公司三星石化股权置换(A股借壳上市)项目；
●中银集团投资有限公司入股京沪高速铁路股份有限公司；
●德龙集团通过破产重整程序并购天津渤海钢铁集团。

Bo Wang, Partner, Commerce & Finance Law Offices
王波，合伙人，通商律师事务所

Mr. Wang Bo graduated from Peking University, LLB and Bachelor of Economics. He started his career in 2003 joining a well-know PRC law firm and has practiced for more than 18 years. His key practice Areas are Securities Investment, Mergers & Acquisition, Reorganization, Private Equity and Real Estate.
Mr. Wang Bo has made sterling accomplishments in the industry’s capital market related businesses. As of now, more than 50% of successful healthcare and biotechnology related IPO projects have seen Mr. Wang’s team’s dedicated participation, representative examples include CR Medical (1515.HK), Jinxin Fertility (1951.HK), Hygeia (6078.HK), Innovent (1801.HK), CanSinoBIO (6185.HK), Alphamab (9966.HK), Akeso (9926.HK) and Innocare (9969.HK).

王波律师毕业于北京大学，拥有法学与经济学双学士学位。他于2003年开始进入知名律师事务所工作，至今已有超过18年的律师执业经验。主要执业领域为：证券投资、并购重组、私募股权和房地产。
王波王律师在医疗资本市场运作方面取得了突出的业绩，截止目前，资本市场上超过半数比例的医疗服务项目IPO和生物科技项目（Biotech）IPO均由王律师团队参与完成，代表性案例包括华润医疗（1515.HK）、锦欣生殖（1951.HK）、海吉亚医疗（6078.HK）、信达生物（1801.HK）、康希诺生物（6185.HK）、康宁杰瑞制药（9966.HK）、康方生物（9926.HK）、诺诚健华（9969.HK）、再鼎医药（ZLAB，美股）、易恒健康（MOHO，美股）。

Liguo Zhang, Chief Partner, Grandway Law Offices
张利国，首席合伙人，国枫律师事务所

As Grandway Law Offices’ chief partner, Mr. Zhang Liguo is a well-known legal expert in China's securities and capital market. He is a member of the 1st Listing Committee of Shanghai Stock Exchange START Market, expert consultant of Asset Securitization Committee of Asset Management Association of China, and member of the Council of the National Fund for Technology Transfer and Commercialization.
As one of the first lawyers establishing law firms and obtaining the professional qualification of securities legal business granted by the Ministry of Justice and the China Securities Regulatory Commission, Mr. Zhang Liguo has helped hundreds of enterprises complete various projects such as stock issuance, mergers and restructuring, additional issuance, rights issue, the establishment of securities investment funds and equity incentive in more than 20 years. And he has been highly praised by clients, partners, regulatory authorities, media and other sectors of society.

张利国律师，北京国枫律师事务所首席合伙人，中国证券与资本市场领域知名法律专家，现任上海证券交易所第一届科创板股票上市委员会委员、中国证券投资基金业协会资产证券化专业委员会专家顾问、国家科技成果转化引导基金理事会理事等职。
作为中国最早一批参加律师事务所创办，并获得司法部、中国证券监督管理委员会授予从事证券法律业务专业资格的律师，张利国律师在20多年间先后帮助数百家企业成功完成股票发行、兼并重组、增发、配股、证券投资基金设立、股权激励等项目，多年来受到客户、合作伙伴、政府机构及媒体等各界高度评价。

Ruiming Jiang, Executive Partner, Grandway Law Offices
姜瑞明，执行合伙人，国枫律师事务所

Mr. Ruiming Jiang is the executive partner of Grandway Law Offices and the core member of China Galaxy Securities Co., Ltd. and Donghai Securities Co., Ltd.. He is also the part-time professor of the Business School in University of International Business and Economics, and the independent director of Beijing Capital International Airport Company Limited and other companies. 
Mr. Ruiming Jiang used to be the member of the 10th and 11th Issuance Examination Commission of the China Securities Regulatory Commission. He is proficient in the legal business about securities issuance, company restructuring and establishment, acquisition and merger, asset reorganization, investment and financing, etc.

姜瑞明律师，北京国枫律师事务所执行合伙人，中国证监会第十、十一届发行审核委员会委员，兼任中国银河证券股份有限公司、东海证券有限责任公司内核委员，对外经贸大学国际商学院外聘教授，首都机场股份有限公司等公司的独立董事。精通证券发行、公司改制设立、收购兼并、资产重组、投融资等领域的法律业务，并积累了丰富的实践经验。